Signal transducers and activators of transcription 3 function in lung cancer

Chun-Jie Li1, Yue-Chuan Li, Dong-Rui Zhang

  • 1Department of Respiratory, Tianjin Chest Hospital, Tianjin 300051, China.

Insights

Signal transducer and activator of transcription 3 (STAT3) proteins drive tumor cell survival in lung cancer. Understanding STAT3 regulation offers potential therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Signal Transduction

Background:

  • Constitutive activation of Signal Transducer and Activator of Transcription 3 (STAT3) proteins is implicated in oncogenic signaling pathways.
  • STAT3 plays a crucial role in regulating tumor cell survival and is a key component of the Janus Activated Kinase/STAT signaling pathway.
  • Aberrant STAT3 activation is observed in approximately 50% of lung cancer cases, highlighting its significance in tumorigenesis.

Purpose of the Study:

  • To review the contribution of STAT3 to lung cancer growth and progression.
  • To discuss the regulatory mechanisms of STAT activation in the context of cancer.
  • To explore therapeutic intervention strategies targeting STAT activation for specific cancers.

Main Methods:

  • Literature review of studies on STAT3 in lung cancer.
  • Analysis of signaling pathways involving STAT3.
  • Examination of regulatory factors influencing STAT activation.

Main Results:

  • STAT3 activation is frequently observed in lung cancer and contributes to tumor growth and progression.
  • Both positive and negative regulation of STAT activation influence cell competition within tumors.
  • Dysregulation of STAT3 signaling is a common feature in various cancers.

Conclusions:

  • STAT3 is a critical mediator in lung cancer development and progression.
  • The complex regulation of STAT activation presents opportunities for targeted cancer therapies.
  • Understanding STAT3's role in cell competition may lead to novel therapeutic approaches for lung cancer.

Related Concept Videos

Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.0K